Skip to main content
. 2020 Aug 15;12(15):15730–15740. doi: 10.18632/aging.103803

Table 3. Treatments and outcomes of non-severe or severe patients of COVID-19 in Guangzhou.

No. (%) P value
Total (288) Non-severe (258) Severe (30)
Treatments
Antiviral 233(80.9) 204(79.1) 29(96.7) 0.020
Antibiotics 244(84.7) 214(82.9) 30(100) 0.014
Vasoactive drugs 5(1.7) 1(0.4) 4(13.3) <0.0001
Glucocorticoid 21(7.3) 12(4.7) 9(30) <0.0001
CRRT 5(1.7) 0(0) 5(16.7) <0.0001
ECMO 4(1.4) 0(0) 4(13.3) <0.0001
Oxygen uptake: .. .. .. ..
None 88(30.6) 84(32.6) 4(13.3) 0.030
Normal-flux 184(63.9) 171(66.3) 13(43.3) 0.013
High-flux 16(5.6) 3(1.2) 13(43.3) <0.0001
Tracheal intubation 8(2.8) 0(0) 8(26.7) <0.0001
Tracheotomy 0(0) 0(0) 0(0) ..
Non-invasive mechanical ventilation 32(11.1) 13(5) 19(63.3) <0.0001
Outcomes
ICU Admission 27(9.4) 12(4.7) 15(50) <0.0001
ARDS 3(1) 0(0) 3(10) <0.0001
Acute kidney injury 5(1.7) 0(0) 5(16.7) <0.0001
Acute cardiac injury 22(11.6) 13(7.6) 9(50) <0.0001

CRRT, continuous renal-replacement therapy; ECMO, Extracorporeal membrane oxygenation; ICU, intensive care unit; ARDS, Acute respiratory distress syndrome.

*P values indicate differences between Severe and Non-severe patients. P<0.05 was considered statistically significant.